Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass

NCT02566733 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Anesthetics, Intravenous
Pharmacology
Anesthetics
Cardiopulmonary Bypass

Interventions

DRUG: Remiva
DRUG: Ultiva

Sponsor

Seoul National University Hospital